Clinical Trials Logo
  1. Home
  2. Bipolar Disorder I
  3. NCT04812379

Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)

Bipolar Disorder I Clinical Trial

Official title:
Abilify Prolonged Release Aqueous Suspension for Intramuscular Injection Specified Drug-use Results Survey (Prevention of Recurrence/Relapse of Mood Episodes in Bipolar I Disorder)

Clinical Trial Summary

To investigate the safety for an observation period of 52 weeks with use of Abilify prolonged release aqueous suspension for intramuscular (IM) injection in patients with bipolar I disorder for prevention of recurrence/relapse of mood episodes in the routine clinical setting. The early stage safety after the switching from oral aripiprazole to this IM injection is investigated including extrapyramidal syndrome and malignant syndrome. Information regarding efficacy is collected as well.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04812379
Study type Observational
Source Otsuka Pharmaceutical Co., Ltd.
Contact
Status Active, not recruiting
Phase
Start date April 7, 2021
Completion date September 2024
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04358900 - Unobtrusive Monitoring of Affective Symptoms and Cognition Using Keyboard Dynamics (UnMASCK)
Recruiting NCT05870501 - Synaptic Imaging and Network Activity in Treatment Resistant Depression N/A
Terminated NCT04058249 - Accelerated Theta Burst Stimulation for Inpatients With Bipolar Disorder N/A
Recruiting NCT01879982 - PSYCHE (Personalised Monitoring SYstems for Care in Mental Health) N/A
Completed NCT05683431 - Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS) N/A
Recruiting NCT05934474 - Biocollection on Peripheral Inflammation
Completed NCT03822416 - Treating Smokers With Mental Illness Phase 2
Recruiting NCT05878730 - Melatonin and Response to Lithium
Not yet recruiting NCT05705063 - Impact of a Ketogenic Diet on Metabolic and Psychiatric Health in Patients With Bipolar Illness N/A
Completed NCT02642029 - Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study N/A
Not yet recruiting NCT04168697 - Effect of Behavioral Intervention on Cannabinoid Receptors in BAD N/A
Recruiting NCT05025605 - Determining Efficacy and Safety of BXCL501 in Agitation Associated With Pediatric Schizophrenia and Bipolar Disorder Phase 1
Completed NCT03692910 - A Study to Evaluate SAGE-217 in Participants With Bipolar I/II Disorder With a Current Major Depressive Episode Phase 2
Not yet recruiting NCT06107764 - Cerebellar Modulation of Cognition in Psychosis N/A